Summerset Group Holdings Ltd (ASX:SNZ) profit up 26%

Summerset Group Holdings Ltd (ASX: SNZ) has advised its underlying profit for the six months to June 30 2018 will rise

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

New Zealand retirement home and hospital group Summerset Group Holdings Ltd (ASX: SNZ) has advised its underlying profit for the six months to June 30, 2018, will be up between 21% and 26% on the previous corresponding period.

According to an earnings guidance announcement today, Summerset will report underlying profit of between NZ$43 million and NZ$45 million for the period off the back of "strong development margins" on settled homes over the first half.

Sales and resales volumes are also on track with full financial results to be handed down on August 14.

On home soil companies intending to cash in on the ageing population include Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) which has been having a tough time of late as its share price tumbled to multi-year lows off the back of challenging industry dynamics and private health insurance declines.

Goldman Sachs placed a sell rating on Ramsay earlier this month, but many investors keen on its growth prospects in the private hospital sector might see it as hovering in buy territory.

Healthscope Ltd (ASX: HSO) shares have also tumbled into the red of late, down 0.2% to $2.24 at the time of writing.

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded

Here’s what analysts at Macquarie rate the stock as now.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

ASX healthcare stock debuts at a massive discount to its initial public offer price

Saluda Medical shares have had a difficult start to public life, trading well below the initial public offer price.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Healthcare Shares

Why CSL shares now look 'massively oversold'

A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Which junior biotech's shares are flying on positive trial news?

This company's shares have surged higher after positive clinical trial results for its stroke treatment drug.

Read more »

Excited elderly woman on a swing.
Healthcare Shares

Guess which ASX 300 healthcare share is lifting off on $25 million news

The ASX 300 healthcare share is grabbing investor interest on Thursday. Let’s see why.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Doomed takeover bid for Mayne Pharma to come to an end

The Mayne Pharma takeover saga appears to be finally drawing to an end, with shareholders bearing the pain of the…

Read more »